Locoregional Control Benefit of a Tumor Bed Boost for Ductal Carcinoma In Situ

Locoregional Control Benefit of a Tumor Bed Boost for Ductal Carcinoma In Situ

Purpose: Radiation therapy (RT) after breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS) reduces invasive and in situ recurrences. Whereas landmark studies suggest that a tumor bed boost improves local control for invasive breast cancer, the benefit in DCIS remains less certain. We...

Full description

Bibliographic Details
Main Authors: Alexandra D. Dreyfuss, MD, Danielle Max, PA, Jessica Flynn, PhD, Zhigang Zhang, PhD, Erin F. Gillespie, MD, Amy Xu, MD, PhD, John Cuaron, MD, Boris Mueller, MD, Atif J. Khan, MD, Oren Cahlon, MD, Simon N. Powell, MD, PhD, Beryl McCormick, MD, Lior Z. Braunstein, MD
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109423000830

Internet

http://www.sciencedirect.com/science/article/pii/S2452109423000830

Similar Items